Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.34p
   
  • Change Today:
      0.14p
  • 52 Week High: 5.60
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 111,579
  • Market Cap: £30.26m
  • Beta: 1.01

Deal with Barclays    Trade now with Barclays Stockbrokers

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

Key Personnel

CEO: Jeremy Skillington
CFO: Ian O’Connel
Executive Chairman: Cathal Friel
Independent Non-Executive Director: Edward Gibson
Independent Non-Executive Director: Luke O’Neill
Independent Non-Executive Director: Brendan Buckley
Non-Executive Dir:

Contact Details

Address: 40 Bank Street, Floor 24, London, United Kingdom, E14 5NR
Phone: +44 (0)20 7183 1499
Website: http://www.poolbegpharma.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BKPG7Z60

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 4.34p
Change Today 0.14p
% Change 3.33 %
52 Week High 5.60
52 Week Low 2.40
Volume 111,579
Shares Issued 697.20m
Market Cap £30.26m
Beta 1.01

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 08-Jan-2026

Time Volume / Share Price
11:05 35,891 @ 4.10p
10:25 53 @ 4.19p
10:22 135 @ 4.44p
09:48 3,190 @ 4.33p
09:21 23,349 @ 4.30p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page